Latvia · Funded startup

Who invested in Longenesis

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Web3 & Crypto

Funding summaryUpdated 26 Oct 2026

$100Kraised across 1 round since 2024, from 1 source

Latest round
Grant, $100KOct 2024
Investors
1
See who backed them

The rounds

  1. Oct 2024
    Grant$100K

    Source recorded

Founders and team

From Longenesis's own website: 1 founder, 5 on the team.

Alex Zhavoronkov PhDFounder and CEO at Insilico Medicine
  • Emil SyundyukovChief Executive Officer
  • Arnolds BogdanovsHead of Technology
  • Garri ZmudzeBoard Member
  • Ieva LasmaneProduct Manager
  • Sergejs JakimovsBoard Member

AdvisersDaniels Pavļuts

Everyone who backed them

PharmStarsAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Longenesis as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

LongeVCVC firmPer its own site
4PM VenturesVenture studioPer its own site

Quick answers about Longenesis

Who invested in Longenesis?

Longenesis's investors include PharmStars.

How much has Longenesis raised?

Longenesis has raised $100K across 1 round since 2024.

When did Longenesis last raise?

Longenesis's most recent round was a Grant of $100K in Oct 2024.

What was Longenesis's biggest round?

Its most recent round, $100K in Oct 2024, is also its largest on record.

Who backed Longenesis first?

Longenesis's first round on record, in Oct 2024, was backed by PharmStars.

What stage is Longenesis at?

Longenesis's latest named round is a Grant, in Oct 2024.

Where is Longenesis based?

Longenesis is based in Latvia.

Companies like Longenesis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.